Christiane Schaefer

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Elimusertib enhances cytotoxic effects of conventional chemotherapy and sensitizes to radiation in preclinical Ewing sarcoma models.

Elimusertib enhances cytotoxic effects of conventional chemotherapy and sensitizes to radiation in preclinical Ewing sarcoma models.

Journal: Scientific reports

Published: October 16, 2025

New cell lines expanding the diversity of Ewing sarcoma models.

New cell lines expanding the diversity of Ewing sarcoma models.

Journal: International journal of cancer

Published: March 24, 2025

Evaluation of the Effect of Photodynamic Therapy on CAM-Grown Sarcomas.

Evaluation of the Effect of Photodynamic Therapy on CAM-Grown Sarcomas.

Journal: Bioengineering (Basel, Switzerland)

Published: January 20, 2023

Ewing Sarcoma as Secondary Malignant Neoplasm-Epidemiological and Clinical Analysis of an International Trial Registry.

Ewing Sarcoma as Secondary Malignant Neoplasm-Epidemiological and Clinical Analysis of an International Trial Registry.

Journal: Cancers

Published: September 29, 2022

Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.

Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden.

Journal: Nature communications

Published: November 19, 2020

The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma.

The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma.

Journal: Cancers

Published: March 07, 2020

Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA.

Correction to: Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 14, 2020

Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA.

Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA.

Journal: European journal of nuclear medicine and molecular imaging

Published: October 02, 2019

The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling.

The CXCR4 antagonist plerixafor (AMD3100) promotes proliferation of Ewing sarcoma cell lines in vitro and activates receptor tyrosine kinase signaling.

Journal: Cell communication and signaling : CCS

Published: January 04, 2018

Target discovery screens using pooled shRNA libraries and next-generation sequencing: A model workflow and analytical algorithm.

Target discovery screens using pooled shRNA libraries and next-generation sequencing: A model workflow and analytical algorithm.

Journal: PloS one

Published: June 11, 2017

Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines.

Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines.

Journal: Anti-cancer drugs

Published: August 05, 2016

Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease.

Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease.

Journal: Molecular oncology

Published: August 12, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026